Diagnosis and treatment of multiple sclerosis: a review
MP McGinley, CH Goldschmidt, AD Rae-Grant - Jama, 2021 - jamanetwork.com
Importance Multiple sclerosis (MS) is an autoimmune-mediated neurodegenerative disease
of the central nervous system characterized by inflammatory demyelination with axonal …
of the central nervous system characterized by inflammatory demyelination with axonal …
Treatment of multiple sclerosis: a review
Multiple sclerosis (MS) is an autoimmune demyelinating and neurodegenerative disease of
the central nervous system, and the leading cause of nontraumatic neurological disability in …
the central nervous system, and the leading cause of nontraumatic neurological disability in …
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS
C Walton, R King, L Rechtman, W Kaye… - Multiple Sclerosis …, 2020 - journals.sagepub.com
Background: High-quality epidemiologic data worldwide are needed to improve our
understanding of disease risk, support health policy to meet the diverse needs of people …
understanding of disease risk, support health policy to meet the diverse needs of people …
Outcomes and risk factors associated with SARS-CoV-2 infection in a North American registry of patients with multiple sclerosis
A Salter, RJ Fox, SD Newsome, J Halper… - JAMA …, 2021 - jamanetwork.com
Importance Emergence of SARS-CoV-2 causing COVID-19 prompted the need to gather
information on clinical outcomes and risk factors associated with morbidity and mortality in …
information on clinical outcomes and risk factors associated with morbidity and mortality in …
A systematic review of the incidence, prevalence, costs, and activity and work limitations of amputation, osteoarthritis, rheumatoid arthritis, back pain, multiple sclerosis …
Objectives To present recent evidence on the prevalence, incidence, costs, activity
limitations, and work limitations of common conditions requiring rehabilitation. Data Sources …
limitations, and work limitations of common conditions requiring rehabilitation. Data Sources …
[HTML][HTML] Therapeutic advances in multiple sclerosis
JH Yang, T Rempe, N Whitmire, A Dunn-Pirio… - Frontiers in …, 2022 - frontiersin.org
Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system that
causes significant disability and healthcare burden. The treatment of MS has evolved over …
causes significant disability and healthcare burden. The treatment of MS has evolved over …
The economic burden of multiple sclerosis in the United States: estimate of direct and indirect costs
Background and Objectives A recent report estimated that approximately 1 million adults
were living with multiple sclerosis (MS) in the United States. Although MS is rarely the direct …
were living with multiple sclerosis (MS) in the United States. Although MS is rarely the direct …
Epidemiology and pathophysiology of multiple sclerosis
M Ward, MD Goldman - CONTINUUM: Lifelong Learning in …, 2022 - journals.lww.com
Epidemiology and Pathophysiology of Multiple Sclerosis : CONTINUUM: Lifelong Learning in
Neurology Account Register Activate Subscription Help Subscribe American Academy of …
Neurology Account Register Activate Subscription Help Subscribe American Academy of …
Environmental and genetic risk factors for MS: an integrated review
Recent findings have provided a molecular basis for the combined contributions of
multifaceted risk factors for the onset of multiple sclerosis (MS). MS appears to start as a …
multifaceted risk factors for the onset of multiple sclerosis (MS). MS appears to start as a …
[HTML][HTML] Alterations of host-gut microbiome interactions in multiple sclerosis
Background Multiple sclerosis (MS) has a complex genetic, immune and metabolic
pathophysiology. Recent studies implicated the gut microbiome in MS pathogenesis …
pathophysiology. Recent studies implicated the gut microbiome in MS pathogenesis …